We’ve gotten used to smartwatches and smart rings that track our steps, heart rate and sleep. Now, a new generation of at-home wearable brain technology is promising to do more, but the latest devices are not all created equal.
Claiming to improve focus, memory and cognition, treat depression, help you sleep better and even ease aches and pains, only a small number of these devices have FDA authorization for specific medical uses. Many others are sold as wellness or brain-training products, for which companies can make broader claims about supporting focus, relaxation or cognitive health without claiming to treat a specific disease, condition or symptom.
The more you look into these devices, the more targeted ads you’re likely to receive and the harder it can be to tell the difference between a wellness claim (“supports memory” or “promotes well-being”) and a medical claim (“slows cognitive decline” or “reduces symptoms of depression”). Pay attention to exactly what a company promises, and do a little research before you buy or try one for yourself or a loved one.
With that said, some clinical trials have had encouraging results with breakthroughs appearing imminent, though researchers caution that the evidence varies considerably by technology and device and more rigorous studies are needed. They agree that consumers should be wary of products promising dramatic improvements in memory, focus or cognition, or relying on customer testimonials to tout their benefits. Legitimate researchers are actively studying these technologies, but many consumer wearable brain devices remain investigational rather than proven treatments.
The following information is based on company claims, expert reviews and research studies.
Electrical Brain Stimulation Headsets
Last year, the FDA approved a brain stimulation headset designed by Flow Neuroscience to treat major depression at home. The device, known as the Flow FL-100, uses transcranial direct current stimulation (tDCS) to send low-intensity electrical currents through electrodes on the scalp to parts of the brain, according to the FDA summary of safety and effectiveness. Flow FL-100, which claims that more than 50% of people in its studies achieved remission from their depression, is expected to be available with a prescription and medical supervision in late 2026 and cost roughly $500-$800.
Weill Cornell Medicine is using tDCS technology for patients who have a history of stroke, traumatic brain injury or movement disorder. Launched in 2023, Weill’s website says this home-based noninvasive brain stimulation program helps “enhance day-to-day functions including talking, walking, and moving both your arms and legs” and “may help to improve responsiveness to physical, occupational and speech therapy.”
The New York University Neuromodulation Lab is studying it to improve cognitive and motor function and is recruiting patients for studies. Since 2019, NYU Langone has offered a tDCS program for people to receive this treatment at home accompanied by telemedicine visits with its researchers.
While tDCS (transcranial direct current stimulation) headsets send current one way through the electrodes and are aimed at making neurons more or less likely to fire, transcranial alternating current stimulation devices are designed to send currents back and forth in order to influence the brain’s natural rhythms. A February 2026 article in Neurology Today said that home-based use of alternating current stimulation shows promise as a potential Alzheimer’s treatment, but added that many newer devices still need larger, well-controlled clinical trials before their benefits and risks are fully understood
40-Hertz Light and Sound Stimulation 
Another promising area of research focuses on 40-hertz stimulation, which uses carefully timed flashing light and pulsed sound to encourage the brain to produce gamma waves — brain rhythms linked to attention, memory and information processing.
Researchers at the Picower Institute for Learning and Memory at MIT discovered in animal studies a decade ago that stimulating the brain at this frequency appeared to reduce some of the hallmark changes associated with Alzheimer’s disease, including amyloid plaques and inflammation.
Since then, small human clinical trials have found the tech to be safe, and have reported encouraging improvements in sleep, brain connectivity and some measures of cognition. But researchers say these early studies involved relatively few participants. Much larger manufacturer-sponsored and university-affiliated studies are currently underway to determine if 40-Hz stimulation can slow cognitive decline or improve memory over the long term.
Cognito Therapeutics, which has developed a 40-Hz headset, is conducting a multiyear randomized trial to determine the safety and efficacy of its Spectris AD device for people with mild to moderate Alzheimer’s.
Pulsed Electromagnetic Field (PEMF) Stimulation
Pulsed electromagnetic field (PEMF) therapy isn’t entirely new. It’s been used clinically since the 1970s, particularly in orthopedics, where certain PEMF devices have been used to stimulate bone growth and help treat fractures that are slow to heal.
Researchers are also investigating PEMF for pain, osteoarthritis, wound healing, nerve injuries and tissue regeneration, with studies suggesting that electromagnetic therapy may influence cellular signaling and other biological processes.
However, a 2023 review emphasizes that PEMF devices use widely varying frequencies, intensities and treatment protocols, making it difficult to draw broad conclusions about what the technology can do.
PEMF and Photobiomodulation
Some newer PEMF wearables claim to support cognitive clarity, focus and memory, with some companies citing peer-reviewed research from institutions like MIT and Harvard when promoting their products.
These devices combine PEMF with photobiomodulation, or light therapy used to stimulate biological activity (an area backed by decades of research in applications such as wound healing, hair loss and some neurological conditions).
More recent research, including small human studies with encouraging results, is investigating whether photobiomodulation can influence brain activity and cognition, but the evidence is still preliminary. Nevertheless, several devices are currently on the market, touting their ability through testimonials and targeted ads to improve memory and cognition.
The BlueVibe by Resona Health ($349), which combines PEMF with 40-Hz blue light, can be worn on the wrist or the back of the neck. Resona markets the wearable as an “FDA general wellness device” for cognitive clarity, focus, memory and emotional balance. Its founder and inventor, Mark Fox, says that during a Phase 1 (in-house) study, the company saw a “100% improvement after six weeks.” In another social media ad, Fox claims that “one woman, 83-years-old, stopped feeling depressed and actually started dancing.” But Resona’s company-reported study was not the kind of randomized clinical trial that would establish verifiable efficacy.
Another example is Nushape’s NeuroPulse Pro ($879), a headband that combines PEMF with red/near-infrared LEDs. The company says it uses certain frequencies “for cognitive clarity.” The manufacturer claims that it can “manage and alleviate” memory impairment and brain fog, and says the 40 Hz it uses can improve brain function. But these are wellness claims, not medical ones.
The bottom line for these types of products is this: There really is science behind the underlying technology, but that doesn’t necessarily mean the specific consumer product and its specific cognitive claims have been clinically established.
Other Wearable Tech
Beyond brain-tech wearables, consumers can now buy wearables aimed at sleep, stress, relaxation and nervous-system regulation, from sleep headbands and neurofeedback devices to noninvasive vagus nerve stimulators (which have been shown to help headache pain but are also being studied for cognition and depression). Some have FDA authorization for specific medical uses, while others are sold strictly as wellness products.
So before trusting a manufacturer’s claims, look for the device in the FDA’s Devices@FDA database to see whether it has actually been cleared or approved, and exactly what it is authorized to do.
Top image: Turgay Koca from berkay08, via Canva.com. Product pics are from manufacturer websites; no endorsement is implied.
